Buscar
Mostrando ítems 21-30 de 548
The Increased Expression of Receptor Activator of Nuclear-kappa B Ligand (RANKL) of Multiple Myeloma Bone Marrow Stromal Cells Is Inhibited by the Bisphosphonate Ibandronate
(WILEY-LISS, DIV JOHN WILEY & SONS INC, 2010-09-01)
The receptor activator of nuclear factor-kappaB ligand (RANKL) and interleukin-1beta are osteoclast activating factors which are abnormally
expressed in bone marrow stromal cells and plasma cells of multiple myeloma ...
Mieloma múltiple en Chile: Características clínicas y sobrevida
(Sociedad Médica de Santiago, 2007)
Características clínicas e implicações prognósticas do acometimento renal no mieloma múltiplo.
(1993-01-01)
The renal involvement in patients with multiple myeloma has been described as a sign of poor prognosis. The influence of renal insufficiency in the clinical patterns and in the prognosis of patients with multiple myeloma ...
Características clínicas e implicações prognósticas do acometimento renal no mieloma múltiplo.
(1993-01-01)
The renal involvement in patients with multiple myeloma has been described as a sign of poor prognosis. The influence of renal insufficiency in the clinical patterns and in the prognosis of patients with multiple myeloma ...
Mieloma múltiple: clínica, paraclínica y principales esquemas de tratamiento Hospital de San José de Bogotá DC. 2003 a 2010
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2012-06-01)
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel – ABHH monoclonal gammopathies committe
Since the World has been facing the COVID-19 pandemic, special attention has been taken
concerning cancer patients; related to their immunosuppression status, adding risk for more
aggressive COVID-19 and mortality, but ...
Fiebre de origen desconocido como forma de presentación atípica de mieloma múltiple: Caso clínico
(Sociedad Médica de Santiago, 2009)
Risk assessment for multiple myeloma: preliminary results of the brazilian myeloma study group
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2008)
The Durie/Salmon staging system continues to be used worldwide in patients with multiple myeloma. However, in recent years, new systems have been proposed. The International Myeloma Working Group performed a retrospective ...